Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial

Clinical trial NCT07529262 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07529262
Sponsor: Curtin University
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Liver Cirrhosis

Start date: 2026-06-01
Primary completion: 2030-06-30
Enrollment: 890

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.